Be A Freedom Fighter · Bill Library
HR 10798 — Silicosis Prevention and Treatment Act
Freedom score: -2 (scale −10 to +10)
- Individual rights: 0
- Property rights: 0
- Economic freedom: -1
- Privacy & due process: 0
- Government power: -1
Sponsor: Rep. Correa, J. Luis [D-CA-46] · Latest action: Referred to the House Committee on Energy and Commerce. (2026-10-13)
Full text on GovInfo (introduced version) · Congress.gov · ← Bill Library index
Findings — 6 highlighted provisions
Each item below is one provision documented in the findings file. The same provision is highlighted in the full text underneath, with its section citation and criterion. Everything else on this page is plain, unreviewed bill text.
- Sec. 1 — supplies the short title only; it changes no private legal obligation See in text ↓
- Sec. 2(a) — directs the HHS Secretary, acting through the HRSA Administrator, to award competitive grants for treatment of people with silicosis irrespective of their ability to pay and for education of workers in industries with high silica exposure. The duty is a grant-program duty, not a command that every private clinic provide uncompensated care or a new silica-exposure workplace standard See in text ↓
- Sec. 2(b)(1)–(4) · Economic Freedom — restricts eligible applicants to federally qualified health centers, hospitals, State/local health departments, or nonprofit health-care clinics/providers. Other providers cannot receive these particular grants merely by meeting the health objective See in text ↓
- Sec. 2(c)(1)–(7) — permits funded outreach, screening/diagnosis/treatment, patient/family/worker education, benefits counseling, care coordination/referrals, pulmonary rehabilitation, and other activities the Secretary determines appropriate. The final clause delegates a narrow discretionary use-of-grants decision; it is not a general power over silica producers See in text ↓
- Sec. 2(d) — defines State to include DC, territories/possessions and Indian Tribes for this grant section See in text ↓
- Sec. 2(e) — authorizes $10 million for each fiscal year 2027–2031. Authorization is not itself an appropriation or proof that grants will be funded or awarded See in text ↓
Full text (introduced version)
17 of 17 text blocks highlighted. Source: GovInfo, fetched cached.
SECTION 1. SHORT TITLE.
Sec. 1 — supplies the short title only; it changes no private legal obligation
SEC. 2. SILICOSIS CLINICS PROGRAM.
Sec. 2(a) — directs the HHS Secretary, acting through the HRSA Administrator, to award competitive grants for treatment of people with silicosis irrespective of their ability to pay and for education of workers in industries with high silica exposure. The duty is a grant-program duty, not a command that every private clinic provide uncompensated care or a new silica-exposure workplace standard
Sec. 2(b)(1)–(4) · Economic Freedom — restricts eligible applicants to federally qualified health centers, hospitals, State/local health departments, or nonprofit health-care clinics/providers. Other providers cannot receive these particular grants merely by meeting the health objective
Sec. 2(b)(1)–(4) · Economic Freedom — restricts eligible applicants to federally qualified health centers, hospitals, State/local health departments, or nonprofit health-care clinics/providers. Other providers cannot receive these particular grants merely by meeting the health objective
Sec. 2(b)(1)–(4) · Economic Freedom — restricts eligible applicants to federally qualified health centers, hospitals, State/local health departments, or nonprofit health-care clinics/providers. Other providers cannot receive these particular grants merely by meeting the health objective
Sec. 2(b)(1)–(4) · Economic Freedom — restricts eligible applicants to federally qualified health centers, hospitals, State/local health departments, or nonprofit health-care clinics/providers. Other providers cannot receive these particular grants merely by meeting the health objective
Sec. 2(b)(1)–(4) · Economic Freedom — restricts eligible applicants to federally qualified health centers, hospitals, State/local health departments, or nonprofit health-care clinics/providers. Other providers cannot receive these particular grants merely by meeting the health objective
Sec. 2(c)(1)–(7) — permits funded outreach, screening/diagnosis/treatment, patient/family/worker education, benefits counseling, care coordination/referrals, pulmonary rehabilitation, and other activities the Secretary determines appropriate. The final clause delegates a narrow discretionary use-of-grants decision; it is not a general power over silica producers
Sec. 2(c)(1)–(7) — permits funded outreach, screening/diagnosis/treatment, patient/family/worker education, benefits counseling, care coordination/referrals, pulmonary rehabilitation, and other activities the Secretary determines appropriate. The final clause delegates a narrow discretionary use-of-grants decision; it is not a general power over silica producers
Sec. 2(c)(1)–(7) — permits funded outreach, screening/diagnosis/treatment, patient/family/worker education, benefits counseling, care coordination/referrals, pulmonary rehabilitation, and other activities the Secretary determines appropriate. The final clause delegates a narrow discretionary use-of-grants decision; it is not a general power over silica producers
Sec. 2(c)(1)–(7) — permits funded outreach, screening/diagnosis/treatment, patient/family/worker education, benefits counseling, care coordination/referrals, pulmonary rehabilitation, and other activities the Secretary determines appropriate. The final clause delegates a narrow discretionary use-of-grants decision; it is not a general power over silica producers
Sec. 2(c)(1)–(7) — permits funded outreach, screening/diagnosis/treatment, patient/family/worker education, benefits counseling, care coordination/referrals, pulmonary rehabilitation, and other activities the Secretary determines appropriate. The final clause delegates a narrow discretionary use-of-grants decision; it is not a general power over silica producers
Sec. 2(c)(1)–(7) — permits funded outreach, screening/diagnosis/treatment, patient/family/worker education, benefits counseling, care coordination/referrals, pulmonary rehabilitation, and other activities the Secretary determines appropriate. The final clause delegates a narrow discretionary use-of-grants decision; it is not a general power over silica producers
Sec. 2(c)(1)–(7) — permits funded outreach, screening/diagnosis/treatment, patient/family/worker education, benefits counseling, care coordination/referrals, pulmonary rehabilitation, and other activities the Secretary determines appropriate. The final clause delegates a narrow discretionary use-of-grants decision; it is not a general power over silica producers
Sec. 2(c)(1)–(7) — permits funded outreach, screening/diagnosis/treatment, patient/family/worker education, benefits counseling, care coordination/referrals, pulmonary rehabilitation, and other activities the Secretary determines appropriate. The final clause delegates a narrow discretionary use-of-grants decision; it is not a general power over silica producers
Sec. 2(d) — defines State to include DC, territories/possessions and Indian Tribes for this grant section
Sec. 2(e) — authorizes $10 million for each fiscal year 2027–2031. Authorization is not itself an appropriation or proof that grants will be funded or awarded
Findings source: bill-scores-v2-batch42-findings-2026-11-15.md. Highlights come only from that file; no finding, score, or provision was invented for this page.
What you can do
Contact your U.S. Representative and Senators about this bill.
Find your Representative Contact your Senators
Spot an error on this page? Report it.